drugset / Trial / NCT07710534
Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a single-center randomized phase 2 open-label clinical trial.
Timeline
- Start
- 2026-09-30
- Primary completion
- 2031-09-30
- Completion
- 2033-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASTX727 | Unknown | — | — |
| Comparator | Azacitidine | Other / unclassified | 75 mg/m2 | — |
| Comparator | Venetoclax | Small molecule | 400 mg | — |
| Comparator | Venetoclax | Small molecule | — | — |